title: [Granulomatous hepatitis following intravesical BCG immunotherapy for cancer of the bladder].
authors.forename: D
authors.initials: D
authors.lastname: Gargot
authors.forename: L
authors.initials: L
authors.lastname: Alexandre
authors.forename: M
authors.initials: M
authors.lastname: Sinico
authors.forename: S
authors.initials: S
authors.lastname: Salmeron
authors.forename: G
authors.initials: G
authors.lastname: Benoit
authors.forename: C
authors.initials: C
authors.lastname: Buffet
mesh_terms: D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
chemical_list: D001500:BCG Vaccine
vernacular_title: Hépatite granulomateuse au cours d'une immunothérapie intravésicale pour cancer de la vessie: 3 observations.